PharmaLab Congress 2026

Symcel will exhibit and present at the PharmaLab Congress 2026, taking place 23–25 November in Darmstadt, Germany.

The PharmaLab Congress brings together laboratory professionals from Analytics, Bioanalytics and Microbiology for knowledge sharing, discussion and networking. Visit us at booth 13 to learn about the Symcel calScreener® and new caloTrace® sterility testing systems for advanced therapies and biologics.

Based on isothermal microcalorimetry technology, which detects microbial presence through highly sensitive monitoring of microbial heat release, the systems combine reliability with continuous monitoring and enable considerably shorter time to results than other growth-based rapid microbial methods. Samples are tested using a non-destructive, direct inoculation workflow that requires no filtration or other sample preparation. The systems can automate the entire testing process, from inoculation to positive/negative results.

Presentations on validation data and implementation strategies

As part of the Alternative and Rapid Microbiological Methods session on 24 November, Symcel and Johnson & Johnson will share insights on validation, technological advancements and approaches to accelerating sterility testing and shortening advanced therapy release timelines.

From 14 Days to 1 Day? Approaches to Accelerate Sterility Testing for Traditional Modalities and Advanced Therapies. 
Nore Struyf, PhD
Principal Scientist, Microbiolology, Johnson & Johnson Innovative Medicine

Advancing Rapid Sterility Testing for Cell and Gene Therapy Products: Primary Validation and Cellular Data with the Automated caloTrace Platform.
Wilhelm Paulander, PhD
Chief Clinical Development Officer, Symcel

Learn more & get in touch

Read more about rapid sterility testing of biologics and pharmaceuticals.
Contact us to schedule a meeting during the event.